Pharmapack Europe 2012

15-16 February 2012, Grande Halle de la Villette, Paris, France

Confirming its continuous expansion, the show will welcome a higher number of participants than last year, with 2,800 visitors from 50 countries expected to join the 250 exhibitors at the Grande Halle de la Villette.  
More info >>

Norwich Expands Capabilities for Phase I-III Clinical Trials

Norwich Clinical Services (NCS), a global provider of clinical research services for the pharmaceutical and biotech industries, today announced a significant expansion to its clinical research capabilities in order to meet growing market demand. Primary to the expansion, NCS unveiled a new clinical facility with capabilities to conduct all aspects of Phase I – III clinical trials including pharmacokinetics in healthy volunteers, bio-availability and bio-equivalence studies, drug metabolism studies, dose proportionality studies and multiple dose studies.
More info >>